NCT07433998 Effect of a Ginger-Based Beverage on Inflammation, Oxidative Stress, and Endothelial Function
| NCT ID | NCT07433998 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Javier Marhuenda |
| Condition | Inflammation Biomarkers |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-03 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-03 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Randomized, double-blind, parallel, placebo-controlled clinical trial designed and conducted to evaluate the effect of daily consumption of ginger, on parameters related to inflammation, oxidative stress, and endothelial damage in adults with excess adiposity.
Eligibility Criteria
Inclusion Criteria: * Male and female participants. * Age between 23 and 65 years. * Body mass index (BMI) \> 27.5 kg/m². * Absence of diagnosed chronic diseases. * Not receiving pharmacological treatment or dietary supplementation on a regular basis. * Ability to understand the study procedures and willingness to comply with study requirements. Exclusion Criteria: * Presence of acute or chronic diseases not specified in the inclusion criteria. * Ongoing chronic pharmacological treatment or active use of dietary supplements. * Major surgery within the previous three months. * Current smokers or recent former smokers (less than six months since cessation). * History of clinically relevant food allergies or eating disorders. * Concurrent participation in another clinical trial or research study. * Pregnancy or breastfeeding. * Following an active weight-loss diet. * Investigator's judgment of unsuitability for study participation.
Contact & Investigator
JAvier Marhuenda Hernández
PRINCIPAL INVESTIGATOR
Universidad Católica San Antonio de Murcia
Frequently Asked Questions
Who can join the NCT07433998 clinical trial?
This trial is open to participants of all sexes, aged 23 Years or older, up to 65 Years, studying Inflammation Biomarkers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07433998 currently recruiting?
Yes, NCT07433998 is actively recruiting participants. Contact the research team at jmarhuenda@ucam.edu for enrollment information.
Where is the NCT07433998 trial being conducted?
This trial is being conducted at Murcia, Spain.
Who is sponsoring the NCT07433998 clinical trial?
NCT07433998 is sponsored by Javier Marhuenda. The principal investigator is JAvier Marhuenda Hernández at Universidad Católica San Antonio de Murcia. The trial plans to enroll 50 participants.